Molecular Phenotype Changes and Personalized Treatment for CRPC
Clinical trial NCT02208583 · UNKNOWN
Trial details
- NCT number
- NCT02208583
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.